Cancer stem cells: perspectives for therapeutic targeting (Q38238005)

31 August 2017

title

Cancer stem cells: perspectives for therapeutic targeting (English)

1 reference

31 August 2017

main subject

neoplastic stem cells

1 reference

Cristina Maccalli

1

1 reference

31 August 2017

Ruggero De Maria

series ordinal

2

1 reference

31 August 2017

publication date

8 August 2014

1 reference

Cancer Immunology, Immunotherapy

31 August 2017

published in

1 reference

31 August 2017

volume

64

1 reference

31 August 2017

issue

1

1 reference

31 August 2017

page(s)

91-97

1 reference

The cancer stem cell: premises, promises and challenges

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Stem cell concepts renew cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Immunology of cancer stem cells in solid tumours. A review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

The quest for self-identity: not all cancer stem cells are the same

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Cancer stem cells and chemosensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

T cells enhance stem-like properties and conditional malignancy in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Therapeutic implications of KIT in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

EphB receptor activity suppresses colorectal cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Tumorigenic and metastatic activity of human thyroid cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Integrin alpha 6 regulates glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Targeting apoptosis pathways in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Thymosin beta4 targeting impairs tumorigenic activity of colon cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Interactions between cancer stem cells and their niche govern metastatic colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

MET: a promising anticancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Identification of selective inhibitors of cancer stem cells by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Sensitivity of a novel model of mammary cancer stem cell-like cells to TNF-related death pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Small-molecule XIAP inhibitors enhance gamma-irradiation-induced apoptosis in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Checkpoint kinase 1 inhibitors for potentiating systemic anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Mesenchymal differentiation of glioblastoma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Novel neutralizing hedgehog antibody MEDI-5304 exhibits antitumor activity by inhibiting paracrine hedgehog signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Effects and mechanisms of anti-CD44 monoclonal antibody A3D8 on proliferation and apoptosis of sphere-forming cells with stemness from human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Immunobiological characterization of cancer stem cells isolated from glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Glioma-associated cancer-initiating cells induce immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Modulation of T-cell activation by malignant melanoma initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Antitumor immunity and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

GDF-15 contributes to proliferation and immune escape of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Crucial role of interleukin-4 in the survival of colon cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Natural killer cells preferentially target cancer stem cells; role of monocytes in protection against NK cell mediated lysis of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Susceptibility of CD24(+) ovarian cancer cells to anti-cancer drugs and natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Soluble mediators from human neural stem cells play a critical role in suppression of T-cell activation and proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

Cancer Stem Cells and Radiotherapy: New Insights Into Tumor Radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1592-1

10.1007/S00262-014-1592-1

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1002776226

0 references

Fatcat ID

release_fta7yfwobrahzcjyvv3ep56hvm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fta7yfwobrahzcjyvv3ep56hvm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference